Alkermes to Participate in Upcoming Investor Conferences

ALKS 11.25.2024

Full Press ReleaseSEC FilingsOur ALKS Tweets

About Gravity Analytica

Recent News

  • 01.15.2025 - 43rd Annual J.P. Morgan Healthcare Conference
  • 01.02.2025 - Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference
  • 12.04.2024 - Piper Sandler 36th Annual Healthcare Conference

Recent Filings

  • 01.13.2025 - EX-99.1 EX-99.1
  • 01.13.2025 - 8-K Current report
  • 12.09.2024 - 144 Report of proposed sale of securities

DUBLIN,Nov. 25, 2024/PRNewswire/ --Alkermes plc(Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences.

7thAnnualEvercore ISI HealthCONx ConferenceDate/Time:Tuesday,Dec. 3, 2024 at10:25 a.m. ET(3:25 p.m. GMT)

Piper Sandler 36thAnnual Healthcare ConferenceDate/Time:Wednesday,Dec. 4, 2024 at4:00 p.m. ET(9:00 p.m. GMT)

The live webcasts may be accessed under the Investors tab onwww.alkermes.comand will be archived for 14 days.

AboutAlkermes plcAlkermes plcis a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence,opioiddependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathichypersomnia. Headquartered inIreland,Alkermesalso has a corporate office and research and development center inMassachusettsand a manufacturing facility inOhio. For more information, please visitAlkermes' website atwww.alkermes.com.

Alkermes Contact:Jamie ConstantineInvestor Relations+1 781 873 2402

Alkermes plc Logo (PRNewsfoto/Alkermes plc)

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-upcoming-investor-conferences-302315492.html

SOURCEAlkermes plc

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com